Published • loading... • Updated
Appleby Advises Voyager Acquisition Corp. In Its Business Combination With Veraxa Biotech AG.
Summary by Conventus Law
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Appleby Advises Voyager Acquisition Corp. In Its Business Combination With Veraxa Biotech AG.
Appleby is pleased to have acted as Cayman Islands legal counsel to Voyager Acquisition Corp. (Voyager) in the closing of its business combination with VERAXA Biotech AG (VERAXA), an emerging leader in designing novel cancer therapies. The shareholders of Voyager approved the business combination on March 12, 2026, and the business combination had been previously approved by VERAXA’s shareholders on February 27, 2026. VERAXA’s shares and warrant…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
